COVID-19 impacts the sexual function of women
https://doi.org/10.23946/2500-0764-2021-6-1-32-40
Abstract
Aim. Sexual function plays an important role in normal human life, along with sleep and food. As it is behind the main human motivations and can manifest itself in any phase of sexual activity or at any time of sexual life, the sexual function is considered as an important factor in determining the quality of life in adults. Here we aimed to estimate the influence of novel coronavirus disease (COVID-19) on the sexual function of women.
Materials and Methods. Our study enrolled 364 women (17-59 years of age) who admitted to the gynecological units of Kemerovo (Russia). A Female Sexual Function Index (FSFI) questionnaire was used to assess the clinical manifestations of sexual dysfunctions. The key FSFI indicators include desire, arousal, lubrication, orgasm, and satisfaction before and during the COVID-19 pandemic, the number of sexual contacts, the age of the partner, the duration of the relationship and cohabitation, and the assumption to have sexual dysfunction.
Results. The sample was divided into 6 age groups: < 17 years (n = 2), 18-29 years (n = 121), 30-39 years (n = 136), 40-49 years (n = 80), 50- 59 years (n = 25), and ≥ 60 years of age (n = 0). All examined parameters of sexual dysfunction have been impacted by the pandemic. In particular, we documented the reduced sexual arousal, lubrication, and satisfaction as well as increased pain during the sexual intercourse. Risk factors for the development of female sexual dysfunction were age of the sexual partner, the duration of the relationship, the frequency of sexual intercourse, and baseline psychological state.
Conclusion. COVID-19 pandemic has been associated with the considerable impairment of the female sexual function.
About the Authors
N. V. ArtymukRussian Federation
Natalia V. Artymuk, Prof., MD, DSc, Head of the Department of Obstetrics and Gynecology named after professor G.A. Ushakova
22a, Voroshilova Street, Kemerovo, 650056
M. N. Surina
Russian Federation
Maria N. Surina, Dr., MD, PhD, Associate Professor, Department of Obstetrics and Gynecology named after professor G.A. Ushakova
22a, Voroshilova Street, Kemerovo, 650056
A. V. Atalyan
Russian Federation
Alina V. Atalyan, Dr., PhD, Senior Researcher, Head of the Functional Group of Information Systems and Biostatistics
16, Timiryazeva Street, Irkutsk, 664003
M. Al-Jefout
Jordan
Moamar Al-Jefout, Dr., MD, JBO & G, MMed (HR&HG), PhD, Associate Professor, Department of Obstetrics & Gynecology, College of Medicine and Health Sciences
Mutah Street, Karak, 61710
E. V. Nekrasova
Russian Federation
Elena V. Nekrasova, Dr., MD, Obstetrician-Gynecologist
22, Oktyabrskiy Prospekt, Kemerovo, 650066
References
1. Clayton AH, Valladares Juarez EM. Female Sexual Dysfunction. Med Clin North Am. 2019;103(4):681-698. https://doi.org/10.1016/j.mcna.2019.02.008
2. Clayton AH, Valladares Juarez EM. Female Sexual Dysfunction. Psychiatr Clin North Am. 2017;40(2):267-284. https://doi.org/10.1016/j.psc.2017.01.004
3. Dawson ML, Shah NM, Rinko RC, Veselis C, Whitmore KE. The evaluation and management of female sexual dysfunction. J Fam Pract. 2017;66(12):722-728.
4. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1):e1-e18. https://doi.org/10.1097/AOG.0000000000003324
5. Kingsberg SA, Schaffr J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA. Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications. J Womens Health (Larchmt). 2019;28(4):432-443. https://doi.org/10.1089/jwh.2018.7352
6. Kingsberg SA, Schaffr J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA. Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications. J Womens Health (Larchmt). 2019;28(4):432-443. https://doi.org/10.1089/jwh.2018.7352
7. Reed GM, Drescher J, Krueger RB, Atalla E, Cochran SD, First MB, Cohen-Kettenis PT, Arango-de Montis I, Parish SJ, Cottler S, Briken P, Saxena S. Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classifcation based on current scientifc evidence, best clinical practices, and human rights considerations. World Psychiatry. 2016;15(3):205-221. https://doi.org/10.1002/wps.20354
8. Flynn KE, Lin L, Bruner DW, Cyranowski JM, Hahn EA, Jeffery DD, Reese JB, Reeve BB, Shelby RA, Weinfurt KP. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med. 2016;13(11):1642-1650. https://doi.org/10.1016/j.jsxm.2016.08.011
9. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T; GSSAB Investigators' Group. Sexual problems among women and men aged 40-80 y: prevalence and correlates identifed in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17(1):39-57. https://doi.org/10.1038/sj.ijir.3901250
10. McCool ME, Zuelke A, Theurich MA, Knuettel H, Ricci C, Apfelbacher C. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies. Sex Med Rev. 2016;4(3):197-212. https://doi.org/10.1016/j.sxmr.2016.03.002
11. Artymuk NV, Surina MN, Atalyan AV, Moamar A-J. COVID-19 and sexual function of women. Fundamental and Clinical Medicine. 2020;5(4):126-132 (in Russ.). https://dx.doi.org/10.23946/2500-0764-2020-5-4-126-132
12. Kogan MI, Kalinchenko SU, Avadieva NE. Prevalence of female sexual dysfunction in Rostov on Don. Urologiia. 2008;(6):41-44. (in Russ.).
13. Kogan MI, Kalinchenko SU, Avadieva NE. Sexual dysfunction in Russia: risk factors for women. Urologiia. 2009;(5):8-12. (in Russ.).
14. Artymuk NV, Khapacheva SY. Device-assisted pelvic foor muscle postpartum exercise programme for the management of pelvic foor dysfunction after delivery. J Matern Fetal Neonatal Med. 2020 Feb 4:1-5. https://doi.org/10.1080/14767058.2020.1723541
15. Artymuk NV, Khapacheva SY. Тhe prevalence of pelvic foor dysfunction (PFD) symptoms in reproductive-aged women. Obstetrics and Gynecology. 2018;(9): 98-104. (in Russ.). https://doi.org/10.18565/aig.2018.9.99-105
16. Stenyaeva NN, Chritinin DF, Chausov AA, Sukhikh GT. Seksual'naia funktsiia i disfunktsiia pri besplodii u zhenshchin [Sexual functioning and sexual dysfunction in women with infertility]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):22-27. (in Russ.). https://dx.doi.org/10.17116/jnevro201711710122-27
17. Stenyaeva NN, Chritinin DF, Chausov AA, Grigoriev VY, Sukhikh GT. Psychopathological characterisitic of infertile women with sexual dysfunctions in assister reproductive technologies programs. Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(5):51-58. (in Russ.). https://dx.doi.org/10.17116/jnevro201911905151
18. Alekseev BYe, Belous IM. Sexual dysfunction in women with psychogenic depression. V.M. Bekhterev Review of psychiatry and medical psychology. 2013;(1):22-24. (in Russ.).
19. Ibarra FP, Mehrad M, Di Mauro M, Godoy MFP, Cruz EG, Nilforoushzadeh MA, Russo GI. Impact of the COVID-19 pandemic on the sexual behavior of the population. The vision of the east and the west. Int Braz J Urol. 2020;46(suppl. 1):104-112. https://dx.doi.org/10.1590/S1677-5538
20. Schiavi MC, Spina V, Zullo MA, Colagiovanni V, Luffarelli P, Rago R, Palazzetti P. Love in the Time of COVID-19: Sexual Function and Quality of Life Analysis During the Social Distancing Measures in a Group of Italian Reproductive-Age Women. J Sex Med. 2020;17(8):1407-1413. https://dx.doi.org/10.1016/j.jsxm.2020.06.006
21. Cocci A, Giunti D, Tonioni C, Cacciamani G, Tellini R, Polloni G, Cito G, Presicce F, Di Mauro M, Minervini A, Cimino S, Russo GI. Love at the time of the Covid-19 pandemic: preliminary results of an online survey conducted during the quarantine in Italy. Int J Impot Res. 2020;32(5):556-557. https://dx.doi.org/10.1038/s41443-020-0305-x
22. Jacob L, Smith L, Butler L, Barnett Y, Grabovac I, McDermott D, Armstrong N, Yakkundi A, Tully MA. Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in the United Kingdom. J Sex Med. 2020;17(7):1229-1236. https://dx.doi.org/10.1016/j.jsxm.2020.05.001
23. Riley T, Sully E, Ahmed Z, Biddlecom A. Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health In Low- and Middle-Income Countries. Int Perspect Sex Reprod Health. 2020;46:73-76. https://dx.doi.org/10.1363/46e9020
24. Li G, Tang D, Song B, Wang C, Qunshan S, Xu C, Geng H, Wu H, He X, Cao Y. Impact of the COVID-19 Pandemic on Partner Relationships and Sexual and Reproductive Health: Cross-Sectional, Online Survey Study. J Med Internet Res. 2020;22(8):e20961. https://dx.doi.org/10.2196/20961
25. Fuchs A, Matonóg A, Pilarska J, Sieradzka P, Szul M, Czuba B, Drosdzol-Cop A. The Impact of COVID-19 on Female Sexual Health. Int J Environ Res Public Health. 2020;17(19):E7152. https://dx.doi.org/10.3390/ijerph17197152
26. Artymuk NV, Belokrinitskaya TE, Filippov OS, Shifman EM. COVID-19 in pregnant women of Siberia and the Far East. Annals of critical care. 2020;2: 41–48. (in Russ.). https://dx.doi.org/10.21320/1818-474X-2020-2-41-48
27. Belokrinitskaya TE, ArtymukNV, Filippov OS, ShifmanEM. Characteristics of the COVID-19 in pregnant women of the Far East and Siberia. Russian Journal of Human Reproduction. 2020;26(3):85- 91. (in Russ.). https://dx.doi.org/10.17116/repro20202603185
28. Ko NY, Lu WH, Chen YL, Li DJ, Chang YP, Wu CF, Wang PW, Yen CF. Changes in Sex Life among People in Taiwan during the COVID-19 Pandemic: The Roles of Risk Perception, General Anxiety, and Demographic Characteristics. Int J Environ Res Public Health. 2020;17(16):5822. https://dx.doi.org/10.3390/ijerph17165822
Review
For citations:
Artymuk N.V., Surina M.N., Atalyan A.V., Al-Jefout M., Nekrasova E.V. COVID-19 impacts the sexual function of women. Fundamental and Clinical Medicine. 2021;6(1):32-40. (In Russ.) https://doi.org/10.23946/2500-0764-2021-6-1-32-40